{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T01:51:31Z","timestamp":1774317091071,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Drug-resistant tuberculosis (DR-TB) continues to pose a threat to public health worldwide. Rifampicin (RIF) resistance is mostly caused by mutations in the\n                      <jats:italic>rpoB<\/jats:italic>\n                      gene, which codes for the \u03b2 -subunit of RNA polymerase and is also an important surrogate marker for multidrug-resistant tuberculosis (MDR).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      This study aimed to detect the\n                      <jats:italic>rpoB<\/jats:italic>\n                      gene mutations associated with RIF resistance and identify the risk factors for MDR\/ RIF resistance patterns in individuals infected with pulmonary TB.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A facility-based cross-sectional study was conducted at selected TB treatment center hospitals (Felegehiwot, Debre-tabor, University of Gondar, Debark, and Metema hospitals) from June to December 2023 in the Northwestern Amhara regional state of Ethiopia. A total of 206 pulmonary TB patient\u2019s sputum samples were included. The study participants\u2019 Socio-demographics and clinical and behavioral characteristics were collected through semi-structured questionnaires. Then all GeneXpert\n                      <jats:sup>\u00ae<\/jats:sup>\n                      MTB\/RI-positive sputum specimens of bacterial isolates were culturedin a conventional egg-based solid Lowenstein-Jensen (LJ) medium. MTB Genomic DNA was extracted using GenoLyze Kit. The allele-specific Amplification Refractory Mutation System Polymerase Chain Reaction (ARMS PCR) approach was employed on whole DNA samples from 206 Culture positive isolates using three distinct codon-specific primers (D516V, H526Y, and S531L).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      An isolate is classified as RR-TB if it carries any mutation in the\n                      <jats:italic>rpoB<\/jats:italic>\n                      gene. Most Single nucleotide polymorphism (SNP) mutations were observed on\n                      <jats:italic>rpoB<\/jats:italic>\n                      S531L 19 (9.2%). Of 206 confirmed clinical isolates, 21 (10.2%) were RIF Resistant, while the remaining 185 (89.8%) were RIF susceptible. Before TB treatment history (AOR\u2009=\u20094.27, CI 1.29\u201314.20,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.02), and Window opening practice of patients (AOR\u2009=\u20096.17, CI 1.22\u201331.29,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.03) were significantly associated with RR-TB development.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The prevalence of RR (RIF Resistant) -TB among TB-confirmed cases was 21 (10.2%). This implies that RR-TB is a serious health problem in the study population. The S531L was the most common mutation conferring resistance to RIF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-025-12351-x","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T04:35:36Z","timestamp":1766032536000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of D516V, H526Y, and S531L rpoB gene polymorphisms and risk factors with rifampicin resistance in Mycobacterium tuberculosis isolates from pulmonary TB patients in Northwest Amhara, Ethiopia: cross-sectional study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8963-7387","authenticated-orcid":false,"given":"Kinfe","family":"Getachew","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aynias","family":"Seid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nega","family":"Berhane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"12351_CR1","unstructured":"WHO. Global tuberculosis report 2022. World Health Organization; 2022."},{"key":"12351_CR2","unstructured":"WHO. Global tuberculosis report 2024. World Health Organization; 2024."},{"issue":"3","key":"12351_CR3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/MCP.0000000000000866","volume":"28","author":"G G\u00fcnther","year":"2022","unstructured":"G\u00fcnther G, Ruswa N, Keller PM. Drug-resistant tuberculosis: advances in diagnosis and management. Curr Opin Pulm Med. 2022;28(3):211\u20137.","journal-title":"Curr Opin Pulm Med"},{"key":"12351_CR4","doi-asserted-by":"crossref","unstructured":"Goletti D, Al-Abri S, Migliori GB, Arlehamn CL, Haldar P, Sundling C, et al. World tuberculosis day 2024 theme Yes! We can end TB can be made a reality through concerted global efforts that advance detection, diagnosis, and treatment of tuberculosis infection and disease. Int J Infect Dis. 2024;141.","DOI":"10.1016\/j.ijid.2024.106993"},{"issue":"1","key":"12351_CR5","doi-asserted-by":"publisher","first-page":"e061836","DOI":"10.1136\/bmjopen-2022-061836","volume":"13","author":"F Admassu","year":"2023","unstructured":"Admassu F, Abera E, Gizachew A, Sedoro T, Gari T. Risk factors of multidrug resistant tuberculosis among patients with tuberculosis at selected multidrug resistance treatment initiative centres in Southern ethiopia: a case-control study. BMJ Open. 2023;13(1):e061836.","journal-title":"BMJ Open"},{"key":"12351_CR6","unstructured":"Brammachary U, Ramachandra V, Palavesam S, Kapalamurthy VRC, Muralidhar A, Muthaiah M. Mechanisms and action of drug resistance on Mycobacterium tuberculosis. Antibiot Resist New Insights. 2022."},{"key":"12351_CR7","doi-asserted-by":"crossref","unstructured":"Sreevatsan S, Pan X, Stockbauer KE, Connell ND, Kreiswirth BN, Whittam TS, et al. Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. Proc Natl Acad Sci U S A. 1997;94(18):9869-74.","DOI":"10.1073\/pnas.94.18.9869"},{"issue":"1","key":"12351_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41479-018-0049-2","volume":"10","author":"R Eddabra","year":"2018","unstructured":"Eddabra R, Ait Benhassou H. Rapid molecular assays for detection of tuberculosis. Pneumonia. 2018;10(1):1\u201312.","journal-title":"Pneumonia"},{"issue":"1","key":"12351_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-14-481","volume":"14","author":"G Mboowa","year":"2014","unstructured":"Mboowa G, Namaganda C, Ssengooba W. Rifampicin resistance mutations in the 81\u00a0bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert\u00ae MTB\/RIF in Kampala, uganda: a retrospective study. BMC Infect Dis. 2014;14(1):1\u20135.","journal-title":"BMC Infect Dis"},{"key":"12351_CR10","unstructured":"CSA. Summary and statistical report of 2007 population and housing censes. Federal Democratic Republic of Ethiopia census Commission, Addis Abeba. Central Statistics Authority; 2007."},{"key":"12351_CR11","unstructured":"Lwanga SK, Lemeshow S, Organization WH. Sample size determination in health studies: a practical manual. World Health Organization; 1991."},{"key":"12351_CR12","doi-asserted-by":"crossref","unstructured":"Jaleta KN, Gizachew M, Gelaw B, Tesfa H, Getaneh A, Biadgo B. Rifampicin-resistant Mycobacterium tuberculosis among tuberculosis-presumptive cases at University of Gondar Hospital, northwest Ethiopia. Infect Drug Resist. 2017:185\u2009\u2013\u200992.","DOI":"10.2147\/IDR.S135935"},{"key":"12351_CR13","doi-asserted-by":"crossref","unstructured":"Seid A, Girma Y, Abebe A, Dereb E, Kassa M, Berhane N. Characteristics of TB\/HIV co-infection and patterns of multidrug-resistance tuberculosis in the Northwest Amhara, Ethiopia. Infect Drug Resist. 2023:3829\u201345.","DOI":"10.2147\/IDR.S412951"},{"key":"12351_CR14","unstructured":"WHO. WHO consolidated guidelines on tuberculosis. Module 3: Diagnosis: World Health Organization; 2025."},{"key":"12351_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ijregi.2022.09.001","volume":"5","author":"G Diriba","year":"2022","unstructured":"Diriba G, Alemu A, Tola HH, Eshetu K, Yenew B, Amare M, et al. Detection of Mycobacterium tuberculosis and rifampicin resistance by Xpert\u00ae MTB\/RIF assay among presumptive tuberculosis patients in addis Ababa, Ethiopia from 2014 to 2021. IJID Reg. 2022;5:97\u2013103.","journal-title":"IJID Reg"},{"issue":"5","key":"12351_CR16","first-page":"775","volume":"87","author":"G Kubica","year":"1963","unstructured":"Kubica G, Dye W, Cohn M, Middlebrook G. Sputum digestion and decontamination with N-acetyl-L-cysteine\u2014sodium hydroxide for culture of mycobacteria. Am Rev Respir Dis. 1963;87(5):775\u20139.","journal-title":"Am Rev Respir Dis"},{"key":"12351_CR17","unstructured":"GLI. Mycobacteriology laboratory manual. Global Laboratory Initiative Advancing TB Diagnosis Geneva Switzerland: World Health Organization. 2014."},{"key":"12351_CR18","volume-title":"Prevention and control programme","author":"TBHIV Tuberculosis, Leprosy","year":"2008","unstructured":"MOH, Tuberculosis, Leprosy TBHIV. Prevention and control programme. Manual: Vol Fourth Edi; 2008."},{"issue":"5","key":"12351_CR19","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1099\/jmm.0.000726","volume":"67","author":"JM Watanabe Pinhata","year":"2018","unstructured":"Watanabe Pinhata JM, Lemes RA, Sime\u00e3o FCS, ARd S, Chimara E, Ferrazoli L. Use of an immunochromatographic assay for rapid identification of Mycobacterium tuberculosis complex clinical isolates in routine diagnosis. J Med Microbiol. 2018;67(5):683\u20136.","journal-title":"J Med Microbiol"},{"issue":"4","key":"12351_CR20","first-page":"DC13","volume":"8","author":"VP Shenoy","year":"2014","unstructured":"Shenoy VP, Mukhopadhyay C. Rapid immunochromatographic test for the identification and discrimination of Mycobacterium tuberculosis complex isolates from non-tuberculous mycobacteria. J Clin Diagn Research: JCDR. 2014;8(4):DC13.","journal-title":"J Clin Diagn Research: JCDR"},{"key":"12351_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jgar.2022.11.012","volume":"32","author":"M Ejo","year":"2023","unstructured":"Ejo M, Torrea G, Diro E, Abebe A, Kassa M, Girma Y, et al. Strain diversity and gene mutations associated with presumptive multidrug-resistant Mycobacterium tuberculosis complex isolates in Northwest Ethiopia. J Global Antimicrob Resist. 2023;32:167\u201375.","journal-title":"J Global Antimicrob Resist"},{"issue":"3","key":"12351_CR22","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1128\/JCM.41.3.993-997.2003","volume":"41","author":"X-Y Fan","year":"2003","unstructured":"Fan X-Y, Hu Z-Y, Xu F-H, Yan Z-Q, Guo S-Q, Li Z-M. Rapid detection of rpoB gene mutations in rifampin-resistant Mycobacterium tuberculosis isolates in Shanghai by using the amplification refractory mutation system. J Clin Microbiol. 2003;41(3):993\u20137.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"12351_CR23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.diagmicrobio.2005.06.007","volume":"53","author":"Z Yang","year":"2005","unstructured":"Yang Z, Durmaz R, Yang D, Gunal S, Zhang L, Foxman B, et al. Simultaneous detection of isoniazid, rifampin, and ethambutol resistance of Mycobacterium tuberculosis by a single multiplex allele-specific polymerase chain reaction (PCR) assay. Diagn Microbiol Infect Dis. 2005;53(3):201\u20138.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"12351_CR24","first-page":"230","volume":"8","author":"T Sisay","year":"2019","unstructured":"Sisay T, Berhane N, Verma D. Molecular biology drug resistance mechanisms and molecular diagnosis methods for tuberculosis. Mol Biology: Open Access. 2019;8:230.","journal-title":"Mol Biology: Open Access"},{"key":"12351_CR25","first-page":"25","volume":"2","author":"J Khadka","year":"2015","unstructured":"Khadka J, Bhatta D, Ghimire P. Molecular characterization of mutation in rpoB gene among rifampicin resistant Mycobacterium tuberculosis isolates in Nepal. J Microbiol. 2015;2:25\u201333.","journal-title":"J Microbiol"},{"issue":"12","key":"12351_CR26","doi-asserted-by":"publisher","first-page":"4435","DOI":"10.1128\/JCM.40.12.4435-4438.2002","volume":"40","author":"C Cavusoglu","year":"2002","unstructured":"Cavusoglu C, Hilmioglu S, Guneri S, Bilgic A. Characterization of rpoB mutations in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Turkey by DNA sequencing and line probe assay. J Clin Microbiol. 2002;40(12):4435\u20138.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"12351_CR27","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1128\/JCM.37.4.1197-1199.1999","volume":"37","author":"G Pozzi","year":"1999","unstructured":"Pozzi G, Meloni M, Iona E, Orr\u00f9 G, Thoresen O, Ricci M, et al. rpoB mutations in multidrug-resistant strains of Mycobacterium tuberculosis isolated in Italy. J Clin Microbiol. 1999;37(4):1197\u20139.","journal-title":"J Clin Microbiol"},{"issue":"7","key":"12351_CR28","first-page":"620","volume":"3","author":"K Schilke","year":"1999","unstructured":"Schilke K, Weyer K, Bretzel G, Amthor B, Brandt J, Sticht-Groh V, et al. Universal pattern of rpoB gene mutations among multidrug-resistant isolates of Mycobacterium tuberculosis complex from Africa. Int J Tuberc Lung Dis. 1999;3(7):620\u20136.","journal-title":"Int J Tuberc Lung Dis"},{"key":"12351_CR29","doi-asserted-by":"crossref","unstructured":"Demissie TA, Belayneh D. Magnitude of Mycobacterium tuberculosis infection and its resistance to rifampicin using Xpert-MTB\/RIF assay among presumptive tuberculosis patients at Motta general Hospital, Northwest Ethiopia. Infect Drug Resist. 2021:1335\u201341.","DOI":"10.2147\/IDR.S300585"},{"key":"12351_CR30","first-page":"1","volume":"10","author":"W Mulu","year":"2017","unstructured":"Mulu W, Abera B, Yimer M, Hailu T, Ayele H, Abate D. Rifampicin-resistance pattern of Mycobacterium tuberculosis and associated factors among presumptive tuberculosis patients referred to Debre Markos referral Hospital, ethiopia: a cross-sectional study. BMC Res Notes. 2017;10:1\u20138.","journal-title":"BMC Res Notes"},{"issue":"2","key":"12351_CR31","doi-asserted-by":"publisher","first-page":"183","DOI":"10.4103\/ejcdt.ejcdt_125_20","volume":"70","author":"S Farghaly","year":"2021","unstructured":"Farghaly S, El-Abdeen AZ, Shaaban LH, Mahmoud A. Epidemiology and outcome of rifampicin resistant tuberculosis in upper Egypt. Egypt J Chest Dis Tuberculosis. 2021;70(2):183\u20137.","journal-title":"Egypt J Chest Dis Tuberculosis"},{"key":"12351_CR32","doi-asserted-by":"crossref","unstructured":"Araya S, Negesso AE, Tamir Z. Rifampicin-resistant Mycobacterium tuberculosis among patients with presumptive tuberculosis in Addis Ababa, Ethiopia. Infect Drug Resist. 2020:3451\u20139.","DOI":"10.2147\/IDR.S263023"},{"key":"12351_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-019-3943-1","volume":"19","author":"B Arega","year":"2019","unstructured":"Arega B, Menbere F, Getachew Y. Prevalence of rifampicin resistant Mycobacterium tuberculosis among presumptive tuberculosis patients in selected governmental hospitals in addis Ababa, Ethiopia. BMC Infect Dis. 2019;19:1\u20135.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"12351_CR34","doi-asserted-by":"publisher","first-page":"e0262929","DOI":"10.1371\/journal.pone.0262929","volume":"17","author":"W Admassu","year":"2022","unstructured":"Admassu W, Ayelign B, Abebe G, Tadesse M. Detection of Mycobacterium tuberculosis and rifampicin resistance by Xpert\u00ae MTB\/RIF assay among presumptive tuberculosis cases at Jimma university medical Center, Southwest Ethiopia. PLoS ONE. 2022;17(1):e0262929.","journal-title":"PLoS ONE"},{"key":"12351_CR35","doi-asserted-by":"crossref","unstructured":"Diriba K, Awulachew E, Churiso G. The magnitude of MTB and rifampicin resistance MTB using Xpert-MTB\/RIF assay among tuberculosis suspected patients in Gedeo Zone, Southern Ethiopia. Infect Drug Resist. 2021:3961\u20139.","DOI":"10.2147\/IDR.S327607"},{"key":"12351_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-016-3210-y","volume":"16","author":"SD Hamusse","year":"2016","unstructured":"Hamusse SD, Teshome D, Hussen MS, Demissie M, Lindtj\u00f8rn B. Primary and secondary anti-tuberculosis drug resistance in Hitossa district of Arsi zone, oromia regional state, central Ethiopia. BMC Public Health. 2016;16:1\u201310.","journal-title":"BMC Public Health"},{"issue":"6","key":"12351_CR37","doi-asserted-by":"publisher","first-page":"e0197737","DOI":"10.1371\/journal.pone.0197737","volume":"13","author":"EA Mesfin","year":"2018","unstructured":"Mesfin EA, Beyene D, Tesfaye A, Admasu A, Addise D, Amare M, et al. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia. PLoS ONE. 2018;13(6):e0197737.","journal-title":"PLoS ONE"},{"issue":"01","key":"12351_CR38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3855\/jidc.2281","volume":"6","author":"PW Ndung\u2019u","year":"2012","unstructured":"Ndung\u2019u PW, Kariuki S, Revathi G. Resistance patterns of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Nairobi. J Infect Developing Ctries. 2012;6(01):33\u20139.","journal-title":"J Infect Developing Ctries"},{"key":"12351_CR39","doi-asserted-by":"publisher","first-page":"205031212211486","DOI":"10.1177\/20503121221148603","volume":"11","author":"MM Ali","year":"2023","unstructured":"Ali MM, Weldegebreal F, Kabew G, Urgesa K. Rifampicin resistant Mycobacterium tuberculosis and associated factors among presumptive pulmonary tuberculosis patients in Mogadishu, Somalia. SAGE Open Med. 2023;11:20503121221148603.","journal-title":"SAGE Open Med"},{"key":"12351_CR40","doi-asserted-by":"crossref","unstructured":"Ikuabe PO, Ebuenyi ID. Prevalence of rifampicin resistance by automated Genexpert rifampicin assay in patients with pulmonary tuberculosis in Yenagoa, Nigeria. Pan Afr Med J. 2018;29.","DOI":"10.11604\/pamj.2018.29.204.14579"},{"key":"12351_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-015-1933-9","volume":"15","author":"K Adane","year":"2015","unstructured":"Adane K, Ameni G, Bekele S, Abebe M, Aseffa A. Prevalence and drug resistance profile of Mycobacterium tuberculosis isolated from pulmonary tuberculosis patients attending two public hospitals in East Gojjam zone, Northwest Ethiopia. BMC Public Health. 2015;15:1\u20138.","journal-title":"BMC Public Health"},{"key":"12351_CR42","doi-asserted-by":"publisher","first-page":"205031212110455","DOI":"10.1177\/20503121211045541","volume":"9","author":"DB Andarge","year":"2021","unstructured":"Andarge DB, Anticho TL, Jara GM, Ali MM. Prevalence of Mycobacterium tuberculosis infection and rifampicin resistance among presumptive tuberculosis cases visiting tuberculosis clinic of Adare general Hospital, Southern Ethiopia. SAGE Open Med. 2021;9:20503121211045541.","journal-title":"SAGE Open Med"},{"key":"12351_CR43","doi-asserted-by":"crossref","unstructured":"Kelecha WT, Teklegiorgis SG-S, Gemechu MM. Rifampicin-resistance pattern of Mycobacterium tuberculosis and associated risk factors among presumptive pulmonary and extra pulmonary tuberculosis patients at Madda Walabu university Goba referral hospital. Southeast Ethiopia. 2021.","DOI":"10.21203\/rs.3.rs-652594\/v1"},{"key":"12351_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-015-1955-3","volume":"15","author":"K Abdella","year":"2015","unstructured":"Abdella K, Abdissa K, Kebede W, Abebe G. Drug resistance patterns of Mycobacterium tuberculosis complex and associated factors among retreatment cases around Jimma, Southwest Ethiopia. BMC Public Health. 2015;15:1\u20137.","journal-title":"BMC Public Health"},{"key":"12351_CR45","doi-asserted-by":"crossref","unstructured":"Abay G, Hailay B. Trends of Mycobacterium Tuberculosis and Rifampicin resistance in Adigrat General Hospital, Eastern zone, Tigray Region, Northern Ethiopia. 2020.","DOI":"10.21203\/rs.2.21744\/v2"},{"issue":"11","key":"12351_CR46","doi-asserted-by":"publisher","first-page":"e77712","DOI":"10.1371\/journal.pone.0077712","volume":"8","author":"YM Coovadia","year":"2013","unstructured":"Coovadia YM, Mahomed S, Pillay M, Werner L, Mlisana K. Rifampicin mono-resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South africa: a significant phenomenon in a high prevalence TB-HIV region. PLoS ONE. 2013;8(11):e77712.","journal-title":"PLoS ONE"},{"key":"12351_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-017-2750-9","volume":"17","author":"SK Masenga","year":"2017","unstructured":"Masenga SK, Mubila H, Hamooya BM. Rifampicin resistance in Mycobacterium tuberculosis patients using GeneXpert at Livingstone central hospital for the year 2015: a cross sectional explorative study. BMC Infect Dis. 2017;17:1\u20134.","journal-title":"BMC Infect Dis"},{"key":"12351_CR48","unstructured":"WHO. Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. World Health Organization; 2014."},{"key":"12351_CR49","doi-asserted-by":"crossref","unstructured":"Seyoum B, Demissie M, Worku A, Bekele S, Aseffa A. Prevalence and drug resistance patterns of Mycobacterium tuberculosis among new smear positive pulmonary tuberculosis patients in eastern Ethiopia. Tuberc Res Treat. 2014;2014.","DOI":"10.1155\/2014\/753492"},{"key":"12351_CR50","unstructured":"Tsegaye A. Comparison of direct microscopy (ziehl neelsen) and light-emitting diode fluorescent microscopy) against Xpert MTB\/RIF for the diagnosis of pulmonary tuberculosis and assessing facility infrastructure in Assosa general hospital Benishangul-gumuz region. Western Ethiopia. 2019."},{"issue":"05","key":"12351_CR51","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3855\/jidc.13265","volume":"15","author":"N Oumer","year":"2021","unstructured":"Oumer N, Atnafu DD, Worku GT, Tsehay AK. Determinants of Multi-drug resistant tuberculosis in four treatment centers of Eastern Amhara, ethiopia: A case-control study. J Infect Developing Ctries. 2021;15(05):687\u201395.","journal-title":"J Infect Developing Ctries"},{"issue":"11","key":"12351_CR52","doi-asserted-by":"publisher","first-page":"e0240361","DOI":"10.1371\/journal.pone.0240361","volume":"15","author":"AG Wasihun","year":"2020","unstructured":"Wasihun AG, Dejene TA, Hailu GG. Frequency of MTB and rifampicin resistance MTB using Xpert-MTB\/RIF assay among adult presumptive tuberculosis patients in Tigray, Northern ethiopia: a cross sectional study. PLoS ONE. 2020;15(11):e0240361.","journal-title":"PLoS ONE"},{"key":"12351_CR53","doi-asserted-by":"crossref","unstructured":"Bodena D, Ataro Z, Tesfa T. Trend analysis and seasonality of tuberculosis among patients at the Hiwot Fana specialized university Hospital, Eastern Ethiopia: a retrospective study. Risk Manage Healthc Policy. 2019:297\u2013305.","DOI":"10.2147\/RMHP.S228659"},{"issue":"12","key":"12351_CR54","doi-asserted-by":"publisher","first-page":"e0277145","DOI":"10.1371\/journal.pone.0277145","volume":"17","author":"GT Akalu","year":"2022","unstructured":"Akalu GT, Tessema B, Petros B. High proportion of RR-TB and mutations conferring RR outside of the RRDR of the rpoB gene detected in GeneXpert MTB\/RIF assay positive pulmonary tuberculosis cases, in addis Ababa, Ethiopia. PLoS ONE. 2022;17(12):e0277145.","journal-title":"PLoS ONE"},{"key":"12351_CR55","doi-asserted-by":"crossref","unstructured":"Kassa GM, Merid MW, Muluneh AG. Khat chewing and clinical conditions determine the epidemiology of primary drug resistance tuberculosis in Amhara region of Ethiopia: a multicenter study. Infect Drug Resist. 2021:2449\u201360.","DOI":"10.2147\/IDR.S316268"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12351-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12351-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12351-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T11:40:45Z","timestamp":1769168445000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12351-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12351"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12351-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"assertion":[{"value":"7 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was obtained from the University of Gondar\u2019s Institutional Review Board (IRB) under reference number VP\/RTT\/05\/142. Each volunteer participant signed a written informed consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors affirm that all participants in this study have given informed consent to publish the data included in this manuscript. Written consent was obtained from all participants, and the authors securely stored the consent forms. No personal identifying information is included in the manuscript, and the data presented does not compromise the privacy or anonymity of the participants involved.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"115"}}